Impact of (68)Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician’s Perspective

Somatostatin receptor imaging with (68)Ga-DOTATATE PET/CT (DOTATATE) is increasingly used for managing patients with neuroendocrine tumors. The objective of this study was to determine referring physicians’ perspectives on the impact of DOTATATE on the management of neuroendocrine tumors. METHODS: A...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Nucl Med
Auteurs principaux: Herrmann, Ken, Czernin, Johannes, Wolin, Edward M., Gupta, Pawan, Barrio, Martin, Gutierrez, Antonio, Schiepers, Christiaan, Mosessian, Sherly, Phelps, Michael E., Allen-Auerbach, Martin S.
Format: Artigo
Langue:Inglês
Publié: 2014
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5068919/
https://ncbi.nlm.nih.gov/pubmed/25500825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.114.148247
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires